| Applications: | Immunodepletion/Immunocompetition |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description : | Golgin A4 Blocking Peptide is synthetically produced from the 2025-2075 sequence and is suitable for use in western blot applications. |
| Formulation: | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: | GOLGA4 |
| Gene ID: | 2803 |
| Uniprot ID: | GOGA4_HUMAN |
| Immunogen Region: | 2025-2075 |
| Immunogen: | Synthetic peptide taken within amino acid region 2025-2075 on human Golgin-245 protein. |
| Function | Involved in vesicular trafficking at the Golgi apparatus level. May play a role in delivery of transport vesicles containing GPI-linked proteins from the trans-Golgi network through its interaction with MACF1. Involved in endosome-to-Golgi trafficking. |
| Peptide Name | Golgin Subfamily A Member 4256 Kda GolginGolgin-245Protein 72.1Trans-Golgi P230 |
| Database Links | Reactome: R-HSA-6811440Reactome: R-HSA-9673768 |
| Cellular Localisation | CytoplasmGolgi Apparatus MembranePeripheral Membrane ProteinGolgi ApparatusTrans-Golgi Network Membrane |
| Alternative Peptide Names | Golgin Subfamily A Member 4 protein256 Kda Golgin proteinGolgin-245 proteinProtein 72.1 proteinTrans-Golgi P230 proteinGOLGA4 protein |
Information sourced from Uniprot.org

